Cytotoxics and High Potency Manufacturing
- All
- APIs
- Aseptic Processing
- cGMP Manufacture
- Cleaning Validation
- Clinical Trial Materials
- Cytotoxics and High Potency Manufacturing
- Excipients
- Extractables and Leachables
- Facilities
- Fill/Finish
- Lyophilization
- Parenterals
- Process Development
- Process Validation
- Risk Management
- Scale-up/ Technology Transfer
- Solid Dosage/ Creams/ Ointments
-
Clinical Trial Materials | Cytotoxics and High Potency Manufacturing | Facilities | Process Development | Scale-up/ Technology Transfer
ADC Bio Invests $11M in Bioconjugation Facility
Will provide capabilities and R&D technical services from process development through to manufacturing09.25.17
-
cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News
-
APIs | Breaking News | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
Cambrex Expands HPAPI Footprint
Invests $24 million in new highly potent API manufacturing capacity at its Charles City, IA facility08.09.17
-
Cytotoxics and High Potency Manufacturing
High Potency APIs: Some Bad News, Some Good News
The growing use of HPAPIs has created some challenges in the lab, while at the same time offering advantages as well.Emil W. Ciurczak, DoraMaxx Consulting 07.18.17
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Cytotoxics and High Potency Manufacturing | Industry News
Mayne Pharma, Metrics Contract Services Designate CoE
The 17,000 sq.-ft. CoE triples the company’s previous stability storage capacity07.11.17
-
APIs | Breaking News | Cytotoxics and High Potency Manufacturing | Industry News
-
Cytotoxics and High Potency Manufacturing
-
Cytotoxics and High Potency Manufacturing | Industry News
Daiichi Sankyo Invests 15B Yen in ADC Mfg. Expansion
To optimize and enhance ADC manufacturing capabilities at three plants in Japan04.27.17
-
Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
Pharmatek Adds cGMP Spray Drying Capacity
Responds to demand for improved pharmaceutical solubility04.26.17
-
Cytotoxics and High Potency Manufacturing | Industry News
Alligator Bioscience Trial Employs Cobra’s MaxXpress Platform
Develops cell line expressing ADC-1013 for CD40 agonistic immuno-oncology using maxXpress service platform04.03.17
-
cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News | Solid Dosage/ Creams/ Ointments
Pfizer CentreOne Expands Service Portfolio
Adds contract manufacturing of highly potent solid oral dose at Ireland facility03.16.17
-
APIs | Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
Patheon Completes Acquisition of Mfg. Site
Gains additional API capacity and major supply agreement with Roche02.03.17
-
APIs | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News
Patheon Completes Acquisition of SC Mfg. Site
Adds capacity for API ranging from development to manufacturing02.01.17
-
APIs | cGMP Manufacture | Cytotoxics and High Potency Manufacturing
Patheon Furthers Expansion Strategy
Patrick Glaser of Patheon discusses expanded manufacturing capacity, capabilities, and future plansOnline Exclusives Kristin Brooks, Contract Pharma 01.09.17
-
Breaking News | CRO News | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
YProtech Adds High Potency Capabilities
Marks the second phase of the CRO’s expansion strategy01.04.17
-
APIs | Cytotoxics and High Potency Manufacturing | Industry News | Inspections
Novasep Custom Mfg. Sites Complete FDA Inspections
Three sites in France and Germany pass U.S. FDA inspection12.20.16
-
APIs | cGMP Manufacture | Cytotoxics and High Potency Manufacturing
Manufacturing Highly Potent Active Pharmaceutical Ingredients
Umicore Precious Metals Chemistry has expanded its Argentinian production siteVideos
-
APIs | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
Patheon Purchases Roche's Florence Mfg. Site
Expands capacity for manufacturing highly potent compounds, adds capabilities11.28.16
-
APIs | Bio News | Breaking News | Cytotoxics and High Potency Manufacturing | Industry News
-
APIs | Breaking News | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
CordenPharma Expands Highly Potent API Capabilities
Completes process bay for category 4 compounds10.17.16
